Cognitive function modulator

A 'Cognitive function modulator' is a broad functional classification describing pharmacological agents that enhance or preserve cognitive domains such as memory, attention, and executive function [1,2]. This term does not refer to a specific molecular target—such as a single receptor, enzyme, or transporter—but rather to a desired therapeutic outcome achieved through diverse biological mechanisms [2,3]. These mechanisms commonly include the enhancement of cholinergic transmission via acetylcholinesterase inhibition, the modulation of glutamatergic signaling through NMDA receptor antagonism, and the regulation of monoaminergic systems [1,4]. Clinically, these modulators are primarily indicated for the treatment of neurodegenerative diseases like Alzheimer's and neurodevelopmental conditions like ADHD [1,5]. Because the term categorizes a class of drugs by their clinical effect rather than a distinct protein or biological entity, it is considered a generic therapeutic description rather than a specific drug target [2,3].

Other names

Cognitive enhancerNootropicSmart drugCognition-enhancing agentCerebroactive drug

Various mechanisms depending on the specific agent, including acetylcholinesterase inhibition, NMDA receptor antagonism, and modulation of monoamine neurotransmitters such as dopamine and norepinephrine.